AzTrials
AzTrials

Diarrhoeal DiseaseNCT01350063

Health Impact of Treating and Safely Storing Shallow Tubewell Drinking Water

A study testing Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab) and Water storage container (Jerry can) in people with Diarrhoeal Disease, run by International Centre for Diarrhoeal Disease Research, Bangladesh at 1 site in Bangladesh.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

When shallow tubewells replaced highly contaminated surface water as the primary source of drinking water in Bangladesh in the late 20th century, contemporary studies demonstrated no reduction in diarrheal disease with this improvement in water source. Read more about this study

Who is it for?
Ages 6 months to 5 yearsHealthy volunteers can take part
Conditions the study is for
Diarrhoeal Disease
What is being tested?
Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab) and Water storage container (Jerry can)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,800 participants
Where
1 siteBangladesh
Study dates
Feb 2011to May 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 5 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Using a shallow tubewell that is free from iron complaints as the bari's primary source of drinking water and
  • Having a child between the ages of six months and two years living in the bari

Who cannot join

  • Iron complaints of the shallow tubewell

Trial locations and contacts

1 site in 1 country.

Bangladesh1 site
  • Fulbaria sub-district

    Mymensingh

Other trials in Bangladesh

About this study

When shallow tubewells replaced highly contaminated surface water as the primary source of drinking water in Bangladesh in the late 20th century, contemporary studies demonstrated no reduction in diarrheal disease with this improvement in water source. This lack of improvement in transitioning to tubewells is consistent with the lack of significant health gains observed in intervention studies focusing on water quality improvements at the source. In contrast, high quality intervention studies that improve water quality at the point of use through treatment of water in households show a 39% reduction in diarrhea.

The primary objective of this study is within a typical setting in rural Bangladesh where households use shallow tubewell water for drinking. The investigators will randomly assign 1800 households who have a child between the ages of six months and two years to one of three groups. Group 1 will receive a safe water storage vessel with a lid and a narrow mouth/tap and Aquatabs, an effervescent water purification tablet that utilizes sodium dichloroisocyanurate (NaDCC) as the chlorine donor. Group 2 will only receive a safe water storage vessel with a lid and a narrow mouth/tap. Group 3 will receive no water intervention and continue their standard habits and practices. Every month a field research assistant will visit each participating household and collect information on the prevalence of diarrhea among children between the ages of six months and two years, as well as children between the ages of two and five years if present in the household. Diarrhea prevalence in the 48 hours and 7 days preceding the visit will be recorded. The investigators will compare the longitudinal prevalence of diarrhea between the following groups: (1) households that receive chlorine and storage container versus households that only receive storage container to assess the effect of chlorination, (2) households that only receive storage container versus households that receive no intervention to assess the effect of safe storage, and (3) households that receive chlorine and storage container versus households that receive no intervention to assess the combined effect of chlorination and safe storage.

Read more

Hypothesis:

Drinking water from shallow tubewells that are intermittently contaminated with enteric pathogens contributes importantly to diarrhea among children in rural Bangladesh.

Read the detailed description

Setting: The investigators will conduct the study in the Fulbaria upazila of Mymensingh district, where groundwater chemistry has been proven to be amenable to disinfection with chlorine. Groundwater in many areas in Bangladesh is rich in iron and other ions that react with chlorine and limit its capacity to provide adequate disinfection. Groundwater testing in Fulbaria has shown that chlorination works effectively at this location, as discussed below.

Develop Intervention: This is an efficacy study, i.e. it is trying to answer the question: if tubewell water were effectively chlorinated and/or safely stored in homes, what would be the impact on childhood diarrhea. To efficiently answer this question, the investigators will strive to optimize the use of the intervention in those households randomized to receive the intervention. Chlorinating water has been shown to be an effective way of disinfecting water in the home (Arnold and Colford, 2007). The investigators will use Aquatabs for chlorination, which are effervescent water purification tablets that utilize sodium dichloroisocyanurate (NaDCC) as the chlorine donor. NaDCC was judged to be a safe and appropriate treatment for water by the World Health Organization (Clasen and Edmondson, 2006) and has been tested and found acceptable to a community of urban residents in Dhaka, Bangladesh (Clasen et al., 2007a). Aquatabs are also easier to store, handle and correctly dose than liquid forms of chlorine (Clasen and Edmondson, 2006).

Groundwater Testing: To optimize the use of Aquatabs and determine the appropriate dose to be assigned to study participants, the investigators collected water samples from 52 shallow tubewells geographically spread out over all 13 unions in Fulbaria. Water was collected in 5L and 10L jerry cans with a narrow mouth and lid. One Aquatabs tablet was added to each vessel, resulting in a free chlorine dose of 2 mg/L in the 10L container and 4 mg/L in the 5L container. Remaining chlorine residual in the vessels was measured half an hour and 24 hours after the addition of the tablet to assess whether it meets the target criteria of having a minimum residual of 0.2 mg/L at 24 hours (to ensure adequate disinfection) and a maximum residual of 2 mg/L at half an hour (to minimize taste and odor concerns). It should be noted that the 2 mg/L taste/odor threshold the investigators are targeting is well under the WHO health limit of 5 mg/L. Based on the testing results, the investigators determined that using one Aquatabs with a 10L jerry can provides the optimal chlorine dose in Fulbaria.

Intervention Groups: The study will have the following three arms, which will allow us to establish the respective roles of household water treatment and safe water storage in preventing diarrheal illness in children in the rural Bangladesh setting.

Group 1 - Aquatabs and Safe Storage Vessel: Households in this group will receive Aquatabs for water purification, a safe water storage container to prevent contamination during storage in the home, and training and encouragement to treat and safely store their water using the provided products.

Group 2 - Safe Storage Vessel: Households in this group will receive a safe water storage container, and training and encouragement to safely store their water using the provided products. If our study shows that treatment of tubewell water at the household level is effective in protecting children's health, they will receive a six-month supply of water treatment tablets at the end of the study.

Group 3 - Standard Practices: Households in this group will not receive any water treatment or storage intervention during the study. They will continue their usual water collection and storage practices. If our study shows that treatment and safe storage of tubewell water at the household level is effective in protecting children's health, they will receive the same safe water storage container as Groups 1 and 2 as well as a six-month supply of water treatment tablets at the end of the study.

Selection of Households: Households to participate in the study will be recruited through a systematic sample from a subset of villages in Fulbaria selected based on field factors such as ease of transport and proximity to the field office. The inclusion criteria will include (1) using a shallow tubewell that is free from iron complaints as the bari's primary source of drinking water and (2) having a child between the ages of six months and two years living in the bari. The primary caregiver in the household that has the child in the target range will be recruited into the study. If there are multiple households in the bari that have a child between the ages of six months and two years, one of the households will be randomly selected and the primary caregiver in the selected household will be recruited. Recruited households will be randomized into one of the three study arms by block randomization through a randomly generated, pre-established sequence that will determine which intervention will be allocated to the household.

Promotion of Interventions: The intervention will continue for five months. At the first visit to the households, Groups 1 and 2 will be provided with a plastic water storage container with a lid and a narrow mouth/tap, and Group 1 will also be given a one-month supply of tablets. Households will be taught through demonstrations and a flipchart with illustrations how to use the tablets as well as how to properly use and clean the safe storage containers, and they will be encouraged to use them regularly. They will also be given an instructions sheet with illustrations that will be left at a visible spot in the household and serve as a reminder to clean the containers and if applicable add the water treatment tablets. A field research assistant who is not part of the evaluation team will visit the household once per month to encourage regular water treatment and safe storage, replenish the supply of tablets and address any issues with the maintenance and cleaning of the safe storage vessels. The rest of the protocol has been written assuming that households will receive monthly promotion visits. However, if the pilot study shows that more frequent, intensive promotion leads to significantly better uptake, in the full-scale study the investigators will consider replacing the monthly promotion frequency with more frequent promotion visits.

Data Collection: There will be one baseline visit and five follow-up visits to participating households.

Baseline Visit: The investigators will conduct a baseline survey including demographics, household description, socioeconomic status, pre-intervention water, sanitation and hygiene habits and baseline levels of diarrhea in children between the ages of six months and two years. If there are any children in a recruited household that are between the ages of two and five, the investigators will collect diarrhea data on them as well to allow comparison of our results to other findings in the literature that focus on children under the age of five. During the baseline visit, the investigators will assess the microbial quality of the tubewell and stored water for each study household using the hydrogen sulphide (H2S) test. Tubewell and stored water samples from a subset of 150 households (50 from each study arm) will be analyzed for total coliforms and E. coli using membrane filtration.

Follow-Up Visits: Every month a field research assistant will visit each participating household to conduct a follow-up survey and collect information on the prevalence of diarrhea among children between the ages of six months and five years in the 48 hours as well as 7 days preceding the visit. The investigators are using a 48-hour recall because this typically provides a more valid estimate than longer recall periods which lead to under-reporting of health outcomes (Alam et al., 1989, Ramakrishnan et al., 1999, Feikin et al., 2010). The investigators are also using a 7-day recall because recent findings indicate that while this longer recall period leads to only minimal bias in terms of the accuracy of recall it can result in significant gains of statistical power (Arnold et al., unpublished data). The investigators will visit households once every month, because more frequent visits provide little additional statistical power due to correlation of repeated measures on the same individuals (Schmidt et al., 2007).

At each visit, the investigators will also collect information on user compliance with the interventions by asking about type and timing of water treatment practices, counting the number of remaining tablets and inspecting the water storage facilities, as well as asking participants when and how they cleaned the storage container. The investigators will also collect water samples from the tubewell and storage container in households to assess the microbial quality of the water, explore the extent of contamination at the source versus in the home and gauge the effectiveness of the interventions in preventing contamination. The investigators will perform H2S testing in half of study households and total coliform/E.coli testing with membrane filtration for a subset of 150 households (50 from each study arm). Moreover, for each household in the Aquatabs group, the investigators will analyze stored water samples for residual chlorine concentration to monitor compliance with the intervention.

Laboratory Testing: Water samples will be placed on ice and transported to the Fulbaria field office where the appropriate tests will be conducted by the field microbiologists. All testing will be performed promptly upon transporting the samples to the field office. The hydrogen sulfide (H2S) test is a simple low-cost test (Sobsey and Pfaender, 2003). Twenty ml of water will be added in H2S bottle and incubated at room temperature for 24-48 hours. If the colour of the water changes to black, it will indicate that the water is contaminated with coliform which will indicate that the water is unfit for human consumption. For membrane filtration, collected water samples will be quantitatively tested for total coliforms and E. coli using the DelAgua kit with MI Broth (Whatman Inc, New Jersey, USA). For residual chlorine testing, the investigators will use the n,n-diethyl-p-phenylenediamine (DPD) colorimetric method which is part of the DelAgua kit.

Being tested
Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab), Water storage container (Jerry can), No intervention
Keywords
water, tubewell, diarrhea, chlorination, safe storage
Medical subject headings
Diarrhea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab)Drug

    Also called Aquatab

    One tablet should be added to 10L container, resulting in a free chlorine dose of 2 mg/L.

  • Water storage container (Jerry can)Device

    Also called Jerry can

    Shallow tubewell water should be stored in 10L container.

  • No interventionOther

Study groups in NCT01350063
Study groupRoleWhat they receive
Aquatabs and Safe Storage VesselExperimentalHouseholds in this group will receive Aquatabs for water purification, a safe water storage container to prevent contamination during storage in the home, and training and encouragement to treat and safely store their water using the provided products.
Receives: Drug: Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab)
Safe Storage VesselExperimentalHouseholds in this group will receive a safe water storage container, and training and encouragement to safely store their water using the provided products. If our study shows that treatment of tubewell water at the household level is effective in protecting children's health, they will receive a six-month supply of water treatment tablets at the end of the study.
Receives: Device: Water storage container (Jerry can)
Standard practiceOtherHouseholds in this group will not receive any water treatment or storage intervention during the study. They will continue their usual water collection and storage practices. If our study shows that treatment and safe storage of tubewell water at the household level is effective in protecting children's health, they will receive the same safe water storage container as Groups 1 and 2 as well as a six-month supply of water treatment tablets at the end of the study.
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diarrhoeal incidence among children between 6 months to 5 years of age.

    6 months' intervention. Follow-up will be done once in a month. Information on diarrhoeal episodes will be collected for 7 days prior to the follow-up day.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2011 (estimated)
  2. Study startFeb 2011
  3. Primary completionMay 2012
  4. Study completionMay 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,800 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01350063
Sponsor's protocol ID
PR-10038
Status last verified
May 2011
First submitted
4 May 2011
Last updated
3 Jan 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Ercumen A, Naser AM, Unicomb L, Arnold BF, Colford JM Jr, Luby SP. Effects of source- versus household contamination of tubewell water on child diarrhea in rural Bangladesh: a randomized controlled trial. PLoS One. 2015 Mar 27;10(3):e0121907. doi: 10.1371/journal.pone.0121907. eCollection 2015.

    PubMed 25816342

Questions about this trial

What is this clinical trial studying?

A study testing Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab) and Water storage container (Jerry can) in people with Diarrhoeal Disease, run by International Centre for Diarrhoeal Disease Research, Bangladesh at 1 site in Bangladesh.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Bangladesh. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diarrhoeal incidence among children between 6 months to 5 years of age. (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01350063, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in